Mpisa S, Soldera J. From kidney to liver: Are sodium–glucose cotransporter-2 inhibitors emerging as metabolic disease modifiers? World J Nephrol 2026; 15(3): 121652 [DOI: 10.5527/wjn.121652]
Please LOGIN to submit a new comment.